These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15474336)
1. Breast cancer: the role of angiogenesis and antiangiogenic therapy. Miller KD; Dul CL Hematol Oncol Clin North Am; 2004 Oct; 18(5):1071-86, ix. PubMed ID: 15474336 [TBL] [Abstract][Full Text] [Related]
2. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer. Ademuyiwa FO; Miller KD Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic therapies in breast cancer. Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic strategies, compounds, and early clinical results in breast cancer. Morabito A; Sarmiento R; Bonginelli P; Gasparini G Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971 [TBL] [Abstract][Full Text] [Related]
5. Triple-negative breast cancer: role of antiangiogenic agents. Greenberg S; Rugo HS Cancer J; 2010; 16(1):33-8. PubMed ID: 20164688 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer. Blackhall FH; Shepherd FA Hematol Oncol Clin North Am; 2004 Oct; 18(5):1121-41, ix. PubMed ID: 15474338 [TBL] [Abstract][Full Text] [Related]
7. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment. Gagne P; Akalu A; Brooks PC Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663 [TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic therapy in the management of breast cancer. Wu Y; Sun WL; Feng JF Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270 [TBL] [Abstract][Full Text] [Related]
9. Molecular targets for breast cancer therapy and prevention. Bange J; Zwick E; Ullrich A Nat Med; 2001 May; 7(5):548-52. PubMed ID: 11329054 [TBL] [Abstract][Full Text] [Related]
10. Current strategies and future directions of antiangiogenic tumor therapy. Zhang ZL; Wang JH; Liu XY Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic therapy for cancer: an update. Shojaei F; Ferrara N Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969 [TBL] [Abstract][Full Text] [Related]
12. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer. Lyons JM; Anthony CT; Thomson JL; Woltering EA Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370 [TBL] [Abstract][Full Text] [Related]
13. Angiogenesis: What can it offer for future medicine? Cao Y Exp Cell Res; 2010 May; 316(8):1304-8. PubMed ID: 20206162 [TBL] [Abstract][Full Text] [Related]
14. The interaction of radiation therapy and antiangiogenic therapy. O'Reilly MS Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126 [TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis and antiangiogenic cancer therapy]. Pour L; Hájek R; Buchler T; Maisnar V; Smolej L Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808 [TBL] [Abstract][Full Text] [Related]
17. Molecular targets as therapeutic strategies in the management of breast cancer. Sartor CI Semin Radiat Oncol; 2002 Oct; 12(4):341-51. PubMed ID: 12382192 [TBL] [Abstract][Full Text] [Related]
19. Angiogenesis of breast cancer. Schneider BP; Miller KD J Clin Oncol; 2005 Mar; 23(8):1782-90. PubMed ID: 15755986 [No Abstract] [Full Text] [Related]
20. Molecular mechanisms and therapeutic development of angiogenesis inhibitors. Cao Y Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]